Hermes Biomaterials Inc.

Private

Ames, IowaHealthcare & Life Scienceshttps://hermesbiomat.com/

Last Round

Debt

Jan 16, 2026

Total Funding Raised

$581,492

Company Overview

Hermes Biomaterials Inc. is a biotechnology company that provides technology solutions to optimize gene editing and transformation in plant cells via biolistics.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

biolistic deliverygene gun technologyplant transformationgene editing toolsFlow Guiding Barrelgene gun attachmentplant biotechnologygenome editingplant sciencebiotech equipmentresearch toolsgold microprojectilescrop bioengineeringuniversity spinoutFGBBio-Rad PDS-1000/He

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hermes Biomaterials Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hermes Biomaterials Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jan 16, 2026
Grant	Aug 22, 2025
Grant	Feb 18, 2025
Grant	Feb 12, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Connor Thorpe

Founder And Chief Technology Officer

Founding Team

Hermes Biomaterials Inc. Investors

Notable investors and investment history

Investor	Rounds
John Pappajohn Iowa Entrepreneurial Venture Competition	Grant
U.S. Department of Energy's National Nuclear Security Administration	Grant
Iowa Economic Development Authority	Debt
Office of Science Consolidated Service Center	Grant
Department of Energy	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 16, 2026
$50K debt round from Iowa Economic Development Authority.
Nov 11, 2025
Grew 150% QoQ from 2 to 5 employees.

View all signals

Hermes Biomaterials Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hermes Biomaterials Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hermes Biomaterials Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAmes, Iowa

Employee Range5

Year Founded2023

Last FundingJan 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.